Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 1PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski PL
02 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
03 1CIPLA LIMITED Mumbai IN
04 1FLEMING LABORATORIES LIMITED Hyderabad IN
05 1JUBILANT PHARMOVA LIMITED Nanjangud IN
06 1PharmaZell GmbH Raubling DE
07 1SYNTHIMED LABS PRIVATE LIMITED Derabassi IN
08 1TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
09 1Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona ES
01 9Risedronate sodium 2.5-hydrate
01 1Germany
02 6India
03 1Poland
04 1Spain
01 7Valid
02 2Withdrawn by Holder
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Risedronate Sodium 2.5-hydrate
Certificate Number : R1-CEP 2013-126 - Rev 02
Status : Valid
Issue Date : 2022-05-09
Type : Chemical
Substance Number : 2572
Risedronate Sodium 2.5-hydrate
Certificate Number : CEP 2013-120 - Rev 02
Status : Valid
Issue Date : 2024-01-11
Type : Chemical
Substance Number : 2572
Risedronate Sodium 2.5-hydrate
Certificate Number : R1-CEP 2014-130 - Rev 00
Status : Valid
Issue Date : 2020-04-28
Type : Chemical
Substance Number : 2572
Risedronate Sodium 2.5-hydrate
Certificate Number : R0-CEP 2021-014 - Rev 00
Status : Valid
Issue Date : 2023-01-05
Type : Chemical
Substance Number : 2572
Risedronate Sodium 2.5-hydrate
Certificate Number : R1-CEP 2014-010 - Rev 01
Status : Valid
Issue Date : 2022-08-23
Type : Chemical
Substance Number : 2572
Risedronate Sodium 2.5-hydrate
Certificate Number : CEP 2014-245 - Rev 01
Status : Valid
Issue Date : 2024-08-01
Type : Chemical
Substance Number : 2572
Risedronate Sodium 2.5-hydrate
Certificate Number : CEP 2013-009 - Rev 01
Status : Valid
Issue Date : 2024-07-30
Type : Chemical
Substance Number : 2572
Risedronate Sodium 2.5-hydrate
Certificate Number : R0-CEP 2016-086 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2017-06-01
Type : Chemical
Substance Number : 2572
Risedronate Sodium 2.5-hydrate
Certificate Number : R0-CEP 2014-025 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2014-09-23
Type : Chemical
Substance Number : 2572
A Risedronate (sodium) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Risedronate (sodium), including repackagers and relabelers. The FDA regulates Risedronate (sodium) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Risedronate (sodium) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Risedronate (sodium) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Risedronate (sodium) supplier is an individual or a company that provides Risedronate (sodium) active pharmaceutical ingredient (API) or Risedronate (sodium) finished formulations upon request. The Risedronate (sodium) suppliers may include Risedronate (sodium) API manufacturers, exporters, distributors and traders.
click here to find a list of Risedronate (sodium) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Risedronate (sodium) CEP of the European Pharmacopoeia monograph is often referred to as a Risedronate (sodium) Certificate of Suitability (COS). The purpose of a Risedronate (sodium) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Risedronate (sodium) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Risedronate (sodium) to their clients by showing that a Risedronate (sodium) CEP has been issued for it. The manufacturer submits a Risedronate (sodium) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Risedronate (sodium) CEP holder for the record. Additionally, the data presented in the Risedronate (sodium) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Risedronate (sodium) DMF.
A Risedronate (sodium) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Risedronate (sodium) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Risedronate (sodium) suppliers with CEP (COS) on PharmaCompass.
We have 8 companies offering Risedronate (sodium)
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
